deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT03207243

Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma

A Randomized, Double-blind, Parallel Group, Multicenter, Stratified Study Evaluating the Efficacy and Safety of Repeat Doses of GSK3772847 Compared With Placebo in Participants With Moderately Severe Asthma

Sponsor: GlaxoSmithKline

Conditions Asthma
Interventions Fluticasone propionate Fluticasone propionate/salmeterol GSK3772847 Placebo
Updated 22 times since 2017 Last updated: Feb 14, 2020 Started: Sep 14, 2017 Primary completion: Feb 15, 2019 Completion: May 15, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Asthma and is currently completed. GlaxoSmithKline leads this study, which shows 22 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Aug 2017 – ~Oct 2017 · 2 months · monthly snapshot~Oct 2017 – ~Dec 2017 · 2 months · monthly snapshot~Dec 2017 – ~Jan 2018 · 31 days · monthly snapshot~Jan 2018 – ~Feb 2018 · 31 days · monthly snapshot~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Jan 2019 · 2 months · monthly snapshot~Jan 2019 – ~Apr 2019 · 3 months · monthly snapshot~Apr 2019 – ~Jul 2019 · 3 months · monthly snapshot~Jul 2019 – ~Apr 2020 · 9 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

22 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 17 earlier versions

  1. Jul 2019 — Apr 2020 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  2. Apr 2019 — Jul 2019 [monthly]

    Active Not Recruiting PHASE2

    Phase: PHASE1_PHASE2 → PHASE2

  3. Jan 2019 — Apr 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting · Phase: PHASE2 → PHASE1_PHASE2

  4. Nov 2018 — Jan 2019 [monthly]

    Recruiting PHASE2

  5. Oct 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  6. Sep 2018 — Oct 2018 [monthly]

    Recruiting PHASE2

  7. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE2

  8. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE2

  9. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2

  10. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

  11. Apr 2018 — May 2018 [monthly]

    Recruiting PHASE2

  12. Mar 2018 — Apr 2018 [monthly]

    Recruiting PHASE2

  13. Feb 2018 — Mar 2018 [monthly]

    Recruiting PHASE2

  14. Jan 2018 — Feb 2018 [monthly]

    Recruiting PHASE2

  15. Dec 2017 — Jan 2018 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  16. Oct 2017 — Dec 2017 [monthly]

    Not Yet Recruiting PHASE2

  17. Aug 2017 — Oct 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GlaxoSmithKline
Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adairsville, United States , Ann Arbor, United States , Bakersfield, United States , Baltimore, United States , Birmingham, United States , Boerne, United States , Chapel Hill, United States , Charlotte, United States , Chelyabinsk, Russia , Cincinnati, United States and 42 more locations